Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

Morphic bags J&J as second big pharma partner for oral integrins
Fierce Biotech
Thu, 02/21/19 - 10:26 am
Tags:
JNJ, AbbVie, Morphic Therapeutic, small-molecule integrins
AbbVie’s JAK inhibitor upadacitinib gets Priority Review
Pharmaforum
Wed, 02/20/19 - 11:23 am
Tags:
AbbVie, upadacatinib, FDA, priority review, rheumatoid arthritis, Humira
2 Pharma Stocks in the Middle of an Oncology Sales Explosion
Motley Fool
Tue, 02/19/19 - 08:01 pm
Tags:
oncology, Roche, AbbVie, AstraZeneca
Hurricanes, droughts, and wildfires: How biopharma is girding for climate change
Stat
Fri, 02/15/19 - 10:29 am
Tags:
climate change, natural disasters, tropical diseases, Takeda, AbbVie, Roche
AbbVie gains option to Teneobio BCMA program
BioCentury
Mon, 02/11/19 - 08:04 pm
Tags:
AbbVie, Teneobio, TNB-383B, Multiple Myeloma
AbbVie loses bid to hoard documents in Humira patent fight with Boehringer
Fierce Pharma
Mon, 02/11/19 - 12:21 pm
Tags:
Boehringer Ingelheim, AbbVie, biosimilars, Humira, patents
Here's Why AbbVie's Stock Tanked in January
Motley Fool
Sat, 02/9/19 - 12:20 pm
Tags:
AbbVie, earnings
Powerful Senate committee invites pharma executives to testify
Reuters
Tue, 02/5/19 - 11:31 pm
Tags:
Senate, drug pricing, AbbVie, AstraZeneca, Bristol-Myers Squibb, JNJ, Merck, Pfizer, Sanofi
Q4 Biopharma Themes: Strong 2018, Weaker 2019 Earnings Projections, Concerns over Drug Pricing
BioSpace
Fri, 02/1/19 - 11:27 am
Tags:
earnings, Pfizer, Amgen, AbbVie, JNJ, Merck, Novo Nordisk, Takeda
3 Big Pharmas Expecting a Softer 2019
Motley Fool
Wed, 01/30/19 - 09:50 am
Tags:
JNJ, AbbVie, Pfizer
FDA Gives Greenlight to Janssen and AbbVie's Imbruvica for the 10th Time
BioSpace
Mon, 01/28/19 - 12:11 pm
Tags:
Imbruvica, Janssen, AbbVie, Roche, Gazyva, chronic lymphocytic leukemia, small lymphocytic lymphoma, FDA
Forget Humira -- Here's What You Need to Know About AbbVie
Motley Fool
Sun, 01/27/19 - 12:13 pm
Tags:
AbbVie, Humira, Upadacitinib, risankizumab, Rick Gonzalez
AbbVie loses $8B in market cap on steeper Humira erosion
BioCentury
Fri, 01/25/19 - 11:20 pm
Tags:
AbbVie, Humira, biosimilars
Coherus BioSciences Announces Settlement with AbbVie to Market its Humira Biosimilar Candidate
CP Wire
Fri, 01/25/19 - 11:53 am
Tags:
Coherus Biosciences, AbbVie, Humira, CHS-1420, biosimilars
Fri, 01/25/19 - 10:41 am
Tags:
Coherus Biosciences, AbbVie, Humira, CHS-1420
AbbVie profit misses as Humira faces biosimilar challenge in Europe
Yahoo/Reuters
Fri, 01/25/19 - 10:14 am
Tags:
AbbVie, earnings, Humira
Johnson & Johnson, AbbVie superstar Imbruvica flunks pancreatic cancer test
Fierce Pharma
Mon, 01/21/19 - 10:54 am
Tags:
AbbVie, JNJ, Imbruvica, pancreatic cancer, clinical trials
AbbVie's Imbruvica misses pancreatic cancer endpoints
BioCentury
Fri, 01/18/19 - 09:16 pm
Tags:
AbbVie, Imbruvica, clinical trials, PCYC-1137, metastatic pancreatic cancer
JPM19: A biotech's M&A invitation, Editas' next CRISPR step and more from day 3
Biopharma Dive
Thu, 01/10/19 - 12:30 pm
Tags:
Editas, CRISPR, GSK, Tesaro, Clovis Oncology, M&A, AbbVie, JPMHC 2019
3 Big Reasons Why AbbVie Isn't Worried About Humira
Yahoo/Motley Fool
Thu, 01/10/19 - 09:47 am
Tags:
AbbVie, Humira, JPMHC 2019

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.